Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chin B Eap

Showing results (111-120 of 179) with videos related to

Pageof 18
Sort By:
Pharmacogenetics and Genomics|October 15, 2016
Prediction of early weight gain during psychotropic treatment using a combinatorial model with clinical and genetic markersFrederik Vandenberghe, Núria Saigí-Morgui, Aurélie Delacrétaz, et al.
Pharmacogenetics and Genomics|February 27, 2016
Association of genetic risk scores with body mass index in Swiss psychiatric cohortsNúria Saigi-Morgui, Frederik Vandenberghe, Aurélie Delacrétaz, et al.
Pharmacopsychiatry|August 13, 2021
Effect of Quetiapine, from Low to High Dose, on Weight and Metabolic Traits: Results from a Prospective Cohort StudyCéline Dubath, Marianna Piras, Mehdi Gholam, et al.
Frontiers in Pharmacology|November 10, 2017
Comparative Long-Term Effect of Three Anti-P2Y12 Drugs after Percutaneous Angioplasty: An Observational Study Based on Electronic Drug Adherence MonitoringValentina Forni Ogna, Isabelle Bassi, Isabelle Menetrey, et al.
Clinical and Translational Science|August 13, 2021
Metabolomic alteration induced by psychotropic drugs: Short-term metabolite profile as a predictor of weight gain evolutionMarie Lenski, Jonathan Sidibé, Mehdi Gholam, et al.
Frontiers in Psychiatry|February 28, 2024
Metabolic disturbances are risk factors for readmission to psychiatric hospitals in non-smokers but not in smokers: results from a Swiss psychiatric cohort and in first-episode psychosis patientsNermine Laaboub, Isabella Locatelli, Claire Grosu, et al.
European Journal of Clinical Pharmacology|April 29, 2004
Oral administration of a low dose of midazolam (75 microg) as an in vivo probe for CYP3A activityChin B Eap, Thierry Buclin, Gianni Cucchia, et al.
The Journal of Clinical Psychiatry|May 13, 2022
Daily Dose Effects of Risperidone on Weight and Other Metabolic Parameters: A Prospective Cohort StudyMarianna Piras, Céline Dubath, Mehdi Gholam, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|April 10, 2024
Pharmacokinetics and Pharmacodynamics of Inhaled Nicotine Salt and Free-Base Using an E-cigarette: A Randomized Crossover StudySamuel E Christen, Laura Hermann, Elias Bekka, et al.
Expert Opinion on Drug Safety|January 3, 2015
Risk-benefit balance assessment of SSRI antidepressant use during pregnancy and lactation based on best available evidenceEtienne Weisskopf, Céline J Fischer, Myriam Bickle Graz, et al.
Pageof 18

Showing results (111-120 of 179) with videos related to

Sort By:
Pageof 18
Pharmacogenetics and Genomics|October 15, 2016
Prediction of early weight gain during psychotropic treatment using a combinatorial model with clinical and genetic markersFrederik Vandenberghe, Núria Saigí-Morgui, Aurélie Delacrétaz, et al.
Pharmacogenetics and Genomics|February 27, 2016
Association of genetic risk scores with body mass index in Swiss psychiatric cohortsNúria Saigi-Morgui, Frederik Vandenberghe, Aurélie Delacrétaz, et al.
Pharmacopsychiatry|August 13, 2021
Effect of Quetiapine, from Low to High Dose, on Weight and Metabolic Traits: Results from a Prospective Cohort StudyCéline Dubath, Marianna Piras, Mehdi Gholam, et al.
Frontiers in Pharmacology|November 10, 2017
Comparative Long-Term Effect of Three Anti-P2Y12 Drugs after Percutaneous Angioplasty: An Observational Study Based on Electronic Drug Adherence MonitoringValentina Forni Ogna, Isabelle Bassi, Isabelle Menetrey, et al.
Clinical and Translational Science|August 13, 2021
Metabolomic alteration induced by psychotropic drugs: Short-term metabolite profile as a predictor of weight gain evolutionMarie Lenski, Jonathan Sidibé, Mehdi Gholam, et al.
Frontiers in Psychiatry|February 28, 2024
Metabolic disturbances are risk factors for readmission to psychiatric hospitals in non-smokers but not in smokers: results from a Swiss psychiatric cohort and in first-episode psychosis patientsNermine Laaboub, Isabella Locatelli, Claire Grosu, et al.
European Journal of Clinical Pharmacology|April 29, 2004
Oral administration of a low dose of midazolam (75 microg) as an in vivo probe for CYP3A activityChin B Eap, Thierry Buclin, Gianni Cucchia, et al.
The Journal of Clinical Psychiatry|May 13, 2022
Daily Dose Effects of Risperidone on Weight and Other Metabolic Parameters: A Prospective Cohort StudyMarianna Piras, Céline Dubath, Mehdi Gholam, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|April 10, 2024
Pharmacokinetics and Pharmacodynamics of Inhaled Nicotine Salt and Free-Base Using an E-cigarette: A Randomized Crossover StudySamuel E Christen, Laura Hermann, Elias Bekka, et al.
Expert Opinion on Drug Safety|January 3, 2015
Risk-benefit balance assessment of SSRI antidepressant use during pregnancy and lactation based on best available evidenceEtienne Weisskopf, Céline J Fischer, Myriam Bickle Graz, et al.
Pageof 18